Skip to main content

Coles N Anthony's Form 4 filing

Cerevel Therapeutics Holdings, Inc. (CERE) · filed Mar 6, 2023

Accession no.
0000899243-23-007176
Filed
Mar 6, 2023
Trade date
Mar 2-3, 2023
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.36M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Coles N AnthonyCIK 0001197018Director, Officer (CEO and Chairperson)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 2, 2023Common StockMOption exerciseAcquired+47,000$3.50+$164,50049,704Direct
Mar 2, 2023Common StockSSaleDisposed−47,000$27.11−$1,274,1702,704Direct
Mar 3, 2023Common StockMOption exerciseAcquired+3,000$3.50+$10,5005,704Direct
Mar 3, 2023Common StockSSaleDisposed−3,000$27.19−$81,5702,704Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 2, 2023Common StockMOption exerciseDisposed−47,000$0.00$02,905,417Direct
Mar 3, 2023Common StockMOption exerciseDisposed−3,000$0.00$02,902,417Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)